Candriam SCA’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Sell |
51,655
-8,662
| -14% | -$2.72M | 0.09% | 194 |
|
|
2025
Q1 | $18.4M | Sell |
60,317
-875
| -1% | -$267K | 0.12% | 169 |
|
|
2024
Q4 | $20.3M | Sell |
61,192
-22,089
| -27% | -$7.34M | 0.12% | 164 |
|
|
2024
Q3 | $27.8M | Buy |
83,281
+8,720
| +12% | +$2.91M | 0.16% | 135 |
|
|
2024
Q2 | $30.7M | Buy |
74,561
+54,255
| +267% | +$22.3M | 0.19% | 119 |
|
|
2024
Q1 | $8.21M | Buy |
+20,306
| New | +$8.21M | 0.05% | 276 |
|
|
2023
Q4 | – | Sell |
-5,750
| Closed | -$1.39M | – | 718 |
|
|
2023
Q3 | $1.39M | Sell |
5,750
-4,144
| -42% | -$1M | 0.01% | 504 |
|
|
2023
Q2 | $2.38M | Buy |
9,894
+6,157
| +165% | +$1.48M | 0.02% | 470 |
|
|
2023
Q1 | $647K | Buy |
+3,737
| New | +$647K | ﹤0.01% | 743 |
|
|
2022
Q4 | – | Sell |
-21,729
| Closed | -$3.42M | – | 878 |
|
|
2022
Q3 | $3.42M | Buy |
+21,729
| New | +$3.42M | 0.02% | 469 |
|